Cover Image

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Show other versions (1)
Saved in:
Bibliographic Details
Main Authors: Stroh, Jacob (Author) , Seckinger, Anja (Author) , Heider, Michael (Author) , Rudelius, Martina (Author) , Eichner, Ruth (Author) , Schick, Markus (Author) , Slawska, Jolanta (Author) , Emde-Rajaratnam, Martina (Author) , Salwender, Hans (Author) , Bertsch, Uta (Author) , Goldschmidt, Hartmut (Author) , Weisel, Katja (Author) , Scheid, Christoph (Author) , Keller, Ulrich (Author) , Hose, Dirk (Author) , Bassermann, Florian (Author)
Format: Article (Journal)
Language:English
Published: 18 January 2022
In: Blood advances
Year: 2022, Volume: 6, Issue: 2, Pages: 515-520
ISSN:2473-9537
DOI:10.1182/bloodadvances.2021005532
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2021005532
Get full text
Author Notes:Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Cristof Scheid, Ulrich Keller, Dirk Hose, and Florian Bassermann
Description
Item Description:Gesehen am 25.03.2022
Physical Description:Online Resource
ISSN:2473-9537
DOI:10.1182/bloodadvances.2021005532

Similar Items